A round-up of CosmeticsDesign-Europe’s most-read news from October 2022 shows interest in why beauty ‘tweakments’ could be cause for concern, Unilever’s big breakthrough plans in deodorants and an expert brainstorm on the future of beauty tech.
Non-surgical cosmetic procedures such as Botox and dermal fillers are rising in popularity, but practitioners and the wider beauty industry must be aware of the long-term impacts to body image these can create on a societal level, say researchers.
Extracts of Acmella oleracea formulated in an “all-natural” emulsion serum can reduce the appearance of wrinkles within two weeks, says a new study that also supports the safety and stability of the serum.
California-based Allergan Inc has had its in-vitro, cell-based assay for testing the stability and potency of Botox and Botox cosmetic, approved by the FDA.
Planet Skincare is readying for the February launch of an
anti-ageing moisturiser early next year that will contain the
award-winning ingredient Syn-ake, based on snake venom.
The molecule Acetyl Hexapeptide is allowing cosmetics manufacturers
to make major inroads in the anti-ageing treatment market,
targeting the consumer need for firmer looking skin and acting as a
stress hormone inhibitor.
![The democratisation of injectables in beauty has seen huge focus on the role of practitioners, but little focus on the lasting impact these procedures have on body image and ideals in society [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/headlines/formulation-science/botox-and-fillers-market-must-consider-sociological-impact-long-term-on-identifies-and-body-image-say-researchers/15829113-1-eng-GB/Botox-and-fillers-market-must-consider-sociological-impact-long-term-on-identifies-and-body-image-say-researchers.jpg)
